Ellington Management Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-3,000
| Closed | -$299K | – | 223 |
|
|
2020
Q1 | $299K | Buy |
3,000
+900
| +43% | +$89.7K | 0.07% | 317 |
|
|
2019
Q4 | $313K | Buy |
+2,100
| New | +$313K | 0.07% | 275 |
|
|
2019
Q2 | – | Sell |
-4,200
| Closed | -$600K | – | 661 |
|
|
2019
Q1 | $600K | Buy |
+4,200
| New | +$600K | 0.11% | 183 |
|
|
2018
Q1 | – | Sell |
-4,700
| Closed | -$633K | – | 912 |
|
|
2017
Q4 | $633K | Buy |
+4,700
| New | +$633K | 0.1% | 154 |
|
|
2016
Q4 | – | Sell |
-3,600
| Closed | -$437K | – | 662 |
|
|
2016
Q3 | $437K | Buy |
+3,600
| New | +$437K | 0.12% | 321 |
|
|
2016
Q1 | – | Sell |
-1,500
| Closed | -$211K | – | 598 |
|
|
2015
Q4 | $211K | Sell |
1,500
-951
| -39% | -$134K | 0.07% | 438 |
|
|
2015
Q3 | $326K | Buy |
+2,451
| New | +$326K | 0.09% | 378 |
|
|
2015
Q1 | – | Sell |
-1,700
| Closed | -$278K | – | 749 |
|
|
2014
Q4 | $278K | Buy |
+1,700
| New | +$278K | 0.09% | 355 |
|
|
2014
Q2 | – | Sell |
-2,400
| Closed | -$333K | – | 564 |
|
|
2014
Q1 | $333K | Buy |
+2,400
| New | +$333K | 0.1% | 325 |
|